Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition

Biochemical and Biophysical Research Communications

Volumn 393, Issue 4, 2010, Pages 614-618

  Yamashita, Akifumi ^a   Kawashita, Norihito ^b   Kubota Koketsu, Ritsuko ^a   Inoue, Yuji ^a   Watanabe, Yohei ^a   Ibrahim, Madiha S ^a   Ideno, Shoji ^c   Yunoki, Mikihiro ^a,c   Okuno, Yoshinobu ^b   Takagi, Tatsuya ^a,b   Yasunaga, Teruo ^a   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Benesis Corporation   (Japan)

Author keywords

Sheet; Global epitope; Human monoclonal antibody; Influenza virus; Vaccine; Virus neutralization

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ;

ARTICLE; BETA SHEET; BINDING SITE; CONTROLLED STUDY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGEN-ANTIBODY REACTIONS; CONSERVED SEQUENCE; EPITOPE MAPPING; EPITOPES; EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS;

AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77949491670     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.031     Document Type: Article

References (28)

1. Carter N.J., and Plosker G.L. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus. BioDrugs 22 (2008) 279-292
2. Pappaioanou M. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?. Comp. Immunol. Microbiol. Infect. Dis. 32 (2009) 287-300
3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Emergence of a novel swine-origin influenza A (H1N1) virus in humans, N. Engl. J. Med. 360 (2009) 2605-2615.
4. Shinde V., Bridges C.B., Uyeki T.M., Shu B., Balish A., Xu X., Lindstrom S., Gubareva L.V., Deyde V., Garten R.J., Harris M., Gerber S., Vagoski S., Smith F., Pascoe N., Martin K., Dufficy D., Ritger K., Conover C., Quinlisk P., Klimov A., Bresee J.S., and Finelli L. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N. Engl. J. Med. 360 (2009) 2616-2625
5. Fouchier R.A., Munster V., Wallenstein A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., and Osterhaus A.D. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79 (2005) 2814-2822
6. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., and Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56 (1992) 152-179
7. Webby R.J., and Webster R.G. Are we ready for pandemic influenza?. Science 302 (2003) 1519-1522
8. Takahashi Y., Hasegawa H., Hara Y., Ato M., Nonomiya A., Takagi H., Odagiri T., Sata T., Tashiro M., and Kobayashi K. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice. J. Infect. Dis. 199 (2009) 1629-1637
9. Kubota-Koketsu R., Mizuta H., Ohshita M., Ideno S., Yunoki M., Kuhara M., Yamamoto N., Okuno Y., and Ikuta K. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem. Biophys. Res. Commun. 387 (2009) 180-185
10. Bao Y., Bolotov P., Dernovoy D., Kiryutin B., Zaslavsky L., Tatusova T., Ostell J., and Lipman D. The Influenza Virus Resource at the National Center for Biotechnology Information. J. Virol. 82 (2008) 596-601
11. Katoh K., and Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief. Bioinform. 9 (2008) 286-298
12. Skehel J.J., and Waterfield M.D. Studies on the primary structure of the influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 72 (1975) 93-97
13. Webster R.G., and Laver W.G. Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 104 (1980) 139-148
14. Wiley D.C., Wilson I.A., and Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
15. Crooks G.E., Hon G., Chandonia J.M., and Brenner S.E. WebLogo: a sequence logo generator. Genome Res. 14 (2004) 1188-1190
16. Rzhetsky A., and Nei M. A simple method for estimating and testing minimum evolution trees. Mol. Biol. Evol. 9 (1992) 945-967
17. Zuckerkandl E., and Pauling L. Evolutionary divergence and convergence in proteins. In: Bryson V., and Vogel H.J. (Eds). Evolving Genes and Proteins (1965), Academic Press, New York 97-166
18. Nei M., and Kumar S. Molecular Evolution and Phylogenetics (2000), Oxford University Press, New York
19. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 (1987) 406-425
20. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24 (2007) 1596-1599
21. Wilson I.A., Skehel J.J., and Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289 (1981) 366-373
22. Gamblin S.J., Haire L.F., Russell R.J., Stevens D.J., Xiao B., Vasisht N., Steinhauer D.A., Daniels R.S., Elliot A., Wiley D.C., and Skehel J.J. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303 (2004) 1838-1842
23. Stevens J., Corper A.L., Basler C.F., Taubenberger J.K., Palese P., and Wilson I.A. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303 (2004) 1866-1870
24. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., and Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312 (2006) 404-410
25. Palese P., and Shaw M.L. Orthomyxoviridae: the viruses and their replication. In: Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Straus S.E. (Eds). Fields Virology. fifth ed. (2007), Lippincott Williams & Wilkins 1647-1689
26. Clements M.I., Betts R.F., Tierney E.L., and Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24 (1986) 157-160
27. Virelizier J.L. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J. Immunol. 115 (1975) 434-439
28. Wang M.L., Skehel J.J., and Wiley D.C. Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J. Virol. 57 (1986) 124-128